Cargando…
Real-World Use of Symptomatic Treatments in Early Alzheimer’s Disease
BACKGROUND: Alzheimer’s disease (AD) is the most common type of dementia, causing progressive decline of memory, thinking, and behavior, impairing daily functioning. Early AD (eAD) includes mild cognitive impairment (MCI) due to AD and mild AD dementia. OBJECTIVE: The aim of this study was to invest...
Autores principales: | Garcia, Maria João, Leadley, Regina, Lang, Shona, Ross, Janine, Vinand, Elizabeth, Ballard, Clive, Gsteiger, Sandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881030/ https://www.ncbi.nlm.nih.gov/pubmed/36404542 http://dx.doi.org/10.3233/JAD-220471 |
Ejemplares similares
-
Estimating the prevalence of diagnosed Alzheimer disease in England across deprivation groups using electronic health records: a clinical practice research datalink study
por: Leahy, Thomas Patrick, et al.
Publicado: (2023) -
GetReal in mathematical modelling: a review of studies predicting drug effectiveness in the real world
por: Panayidou, Klea, et al.
Publicado: (2016) -
Combining individual patient data from randomized and non-randomized
studies to predict real-world effectiveness of interventions
por: Seo, Michael, et al.
Publicado: (2022) -
A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529)
por: Mohammed, Hassen, et al.
Publicado: (2023) -
Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer’s Coordinating Center Uniform Data Set
por: Crowell, Valerie, et al.
Publicado: (2023)